A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma
Clinical trial NCT02783599 · COMPLETED
Trial details
- NCT number
- NCT02783599
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-11
- Primary completion
- 2018-07-05
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.